Centre Paul Strauss
Strasbourg, 67033, France
Location status: Recruiting
Location contact
Claire DOSSUN
SUB_INVESTIGATOR
Georges NOEL
SUB_INVESTIGATOR
Laura BOINOT-FRITSCH
PRINCIPAL_INVESTIGATOR
Manon VOEGELIN
CONTACT
Valérie SARTORI
CONTACT
NCT Number: NCT06330142
This study proposes a horse-assisted therapy (HAT) approach to accompany children and young adults undergoing irradiation in the ICANS Radiotherapy Department.
The aim of this new approach is to improve quality of life and reduce anxiety in children and adolescents treated with radiotherapy. The impact of equine-assisted therapy on quality of life and anxiety disorders will be described prospectively between the start and end of irradiation in children and parents who agree to inclusion.
Interested in participating?
Request Info8 year–17 year
All sexes
Interventional
Not applicable
Strasbourg, 67033, France
Location status: Recruiting
Claire DOSSUN
SUB_INVESTIGATOR
Georges NOEL
SUB_INVESTIGATOR
Laura BOINOT-FRITSCH
PRINCIPAL_INVESTIGATOR
Manon VOEGELIN
CONTACT
Valérie SARTORI
CONTACT
Electro-radiology medical technician (ERMT) are privileged contacts with children. They accompany them every day during radiotherapy sessions. An animal-mediated approach would provide a new out-of-hospital environment. The equine sessions, precious moments when the child can forget about his illness, would enable him to escape from his condition as a patient. Indeed, the sick child adopts a posture to withstand treatment and take on responsibilities such as "not crying" and "being brave". These moments, away from the hospital, are essential to the smooth running of care, since they limit the weariness induced by daily radiotherapy sessions and help preserve the quality of caregiver/child cooperation during treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
supporting children and teenagers undergoing radiotherapy with a horse-assisted therapy approach
Time frame: before radiotherapy, halfway through the HAT sessions (at 5 weeks), at the end of the HAT sessions (at 10 weeks) and one month after the end of the HAT sessions
The questionnaire used to assess quality of life will be completed by the child.
Two versions of the VSP-A questionnaire exist, depending on the child's age (versions < 10 years and 10-17 years).
Results can be compared with reference values for the general population.
Time frame: before radiotherapy, halfway through the HAT sessions (at 5 weeks), at the end of the HAT sessions (at 10 weeks) and one month after the end of the HAT sessions
Parents (or carers) will complete a questionnaire to assess their child's quality of life.
Time frame: before radiotherapy, halfway through HAT sessions (at 5 weeks), at the end of HAT sessions (at 10 weeks) and one month after the end of HAT sessions
The questionnaire used to assess anxiety will be completed by the child (SCARED child version)
Time frame: before radiotherapy, halfway through HAT sessions (at 5 weeks), at the end of HAT sessions (at 10 weeks) and one month after the end of HAT sessions
Parents (or carers) will also complete a questionnaire to assess their child's anxiety (SCARED parents' version)
Time frame: at the start and end of radiotherapy sessions (from 3 to 7 weeks)
Evaluation of acute toxicities induced by radiotherapy CTCAE version 5 scale
Time frame: At every HAT sessions (up to 10 weeks)
Study the link between the various equestrian activities and the quality of life reported by children. Dashboard to track the duration of each activity carried out per child and per session, completed by the equestrian.
Time frame: at the beginning and end of HAT sessions (up to 10 weeks)
questionnaire
Time frame: every week during radiotherapy (from 3 to 7 weeks)
MERT's assessment of the impact of HAT on the child's well-being, based on a retrospective questionnaire for the previous week.
Time frame: at each radiotherapy session (from 3 to 7 weeks)
Time frame: at the end of the first session and at the end of the last session of HAT (up to 10 weeks)
Equestrian appreciation of the impact of HAT on the child's well-being during HAT sessions using questionnaires
Time frame: at the end of the HAT sessions (at 10 weeks)
Open questionnaire at the end of HAT to be completed by parents
Contact information is provided by the study sponsor or research team.
Centre Paul Strauss
Other
T-QAP: radioTherapy eQuicie Adolescent - Pediatrics
Acronym: T-QAP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07724548
Radiotherapy
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT05417516
Breast Neoplasm Female, Cosmetic Outcome
Darlinghurst, New South Wales, Australia
View Trial DetailsNCT07339488
Borderline Resectable Carcinoma, Carcinoma
Shantou, Guangdong, China
View Trial DetailsNCT07646639
Colorectal Neoplasms, Digestive System Diseases
Nanjing, Jiangsu, China
View Trial Details